February 6, 2020 8:13am
Expect to expect it
Pre-open indications: 3 SELLs and 1 BUY
Who is defining the metrics for individual investors? Spare the SELL or BUY call, underfund the portfolio – SUBSCRIBE!
Dow future are UP +0.37% (+107 points), S&P futures are UP +0.34% (+11 points) and NASDAQ futures are UP +0.42% (+40 points)
U.S. stock index futures are rising with economic data and for our sector, Alnylam Pharmaceuticals (ALNY) earnings, while fears over the coronavirus outbreak continued to sidetrack investors;
Europe markets climb as virus fears subside as the pan-European Stoxx 600 climbed +0.5% in early trade;
Asia Pacific markets jumped in reaction to positive developments on the U.S.-China trade front. Beijing said Thursday it would halve tariffs on hundreds of U.S. imports from 1:01 p.m. on Feb. 14, according to a statement on the Ministry of Finance’s website;
Data Docket: weekly jobless claims are due at 8:30 a.m. ET, as well as preliminary fourth-quarter productivity figures and labor costs.
As the leading voice of cell and gene therapy investors; I am not always a doom and gloom analyst/journalist but a man who has been “there” (BUY, SELL, VC and operating roles) with the gray hair and a readership following with real numbers to prove it so I get to pontificate!
US futures point to 4th straight day of gains … how sustainable is it and for how Long
Markets also received a boost from the announcement from China’s Ministry of Finance that Beijing is set to halve tariffs on hundreds of U.S. imports worth around $75 billion. Tariffs on some U.S. goods will be cut from 10% to 5%, and from 5% to 2.5% on others, which will take effect on Feb. 14.
It was also announced by Reuters which cited reports “that said a research team at Zhejiang University had found a drug to treat people infected by the new coronavirus.”
Just like algorithms, rules-are-what-we-make-of-them. The take-away, don’t dwell on what’s happening but, learn the lesson of timing – Q4 LPS (loss-per-share) results are starting while many others are being “formulated”.
Wednesday night’s post’s title: “: expectation, a strong belief that something will happen or be the case in the future”
- The IBB closed up +3.01% and XBI closed up +2.33%
- The NASDAQ closed UP +40.71 points (+0.43%)
- The close was positive with an A/D line of 27/5, 3 flats of 35 covered,
- The range of the 27 upside was +0.56% (BLFS) to +22.77% (ADRO) while the 5 downside ranged from -0.02% (IONS) to -17.81% (BLCM);
- 4 out of the 27 upside had higher than the 3-month average volume;
- 1 out of the 5 downside had higher than the 3-month average volume;
February registered 3 positive closes – so far.
January registered 10 positive, 9 negative closes and 2 holidays.
- December register 11 negative and 10 positive closes
- November registered 1 holiday, 12 positive and 8 negative close;
- October registered 10 positive, 1 neutral and 14 negative closes;
Companies in my headlights – It’s your decision; I provide an idea and context:
Pre-open indications: SELL – AGTC on news of offering, ALNY on earnings release and ADRO on sudden upside spiral – a trading target. BUY - VSTM
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.